MedVellum
MedVellum
Back to Library
Emergency Medicine
Endocrinology
Acute Medicine
EMERGENCY

Hypoglycaemia in Adults

High EvidenceUpdated: 2024-12-21

On This Page

Red Flags

  • GCS below 8 or seizure
  • Unable to self-treat
  • Recurrent hypoglycaemia
  • Hypoglycaemia unawareness
  • Prolonged hypoglycaemia over 30 minutes
  • Post-sulphonylurea hypoglycaemia (can recur)
Overview

Hypoglycaemia in Adults

Clinical Overview

Summary

Hypoglycaemia is defined as blood glucose below 4.0 mmol/L. In diabetic patients, it is most commonly caused by insulin or sulphonylureas with inadequate carbohydrate intake. Severe hypoglycaemia can cause seizures, coma, and brain damage. Treatment depends on consciousness: oral glucose if conscious, IV dextrose or IM glucagon if unconscious.

Key Facts

  • Definition: Blood glucose below 4.0 mmol/L ("4 is the floor")
  • Severe hypoglycaemia: Requiring third-party assistance
  • Neuroglycopenic symptoms: Appear at glucose below 3.0 mmol/L
  • Brain damage threshold: Prolonged glucose below 2.0 mmol/L
  • Sulphonylurea hypoglycaemia: Can recur — observe for 24-48 hours

Clinical Pearls

"4 is the floor" — treat any glucose below 4.0 mmol/L even if asymptomatic

Sulphonylurea-induced hypoglycaemia can last 24-72 hours — ADMIT

Rebound hyperglycaemia after treatment is common — avoid overtreating

Why This Matters Clinically

Hypoglycaemia is the major limiting factor to achieving good glycaemic control in diabetes. Repeated episodes cause impaired awareness, creating a dangerous cycle. Recognition and appropriate treatment prevents serious neurological sequelae.


Epidemiology

Incidence

  • Type 1 diabetes: 1-2 severe episodes per patient per year
  • Type 2 diabetes on insulin: 0.3-0.5 episodes per patient per year
  • Type 2 diabetes on sulphonylureas: 0.2-0.4 episodes per patient per year

Risk Factors

FactorMechanism
Insulin/sulphonylurea useExcess insulin effect
Missed mealsInadequate glucose intake
ExerciseIncreased glucose utilisation
AlcoholImpaired gluconeogenesis
Renal impairmentReduced drug clearance
Long diabetes durationHypoglycaemia unawareness
Previous severe hypoglycaemiaPredictive of future events

Pathophysiology

Normal Counter-Regulatory Response

  1. Falling glucose: Insulin secretion stops
  2. Glucose ~3.6 mmol/L: Glucagon release
  3. Glucose ~3.2 mmol/L: Adrenaline release
  4. Lower levels: Cortisol, GH release

Failure in Diabetes

  • Exogenous insulin cannot be "switched off"
  • Type 1: Glucagon response lost within 5 years
  • Repeated hypos: Impaired adrenaline response → unawareness

Symptoms by Mechanism

Autonomic (Adrenergic)Neuroglycopenic
SweatingConfusion
TremorDrowsiness
PalpitationsDifficulty speaking
HungerIncoordination
AnxietySeizures

Classification

By Severity (International Hypoglycaemia Study Group)

LevelGlucoseClinical
Level 1 (Alert)Below 4.0 mmol/LSymptomatic, self-treatable
Level 2 (Serious)Below 3.0 mmol/LNeuroglycopenic symptoms
Level 3 (Severe)AnyRequires third-party assistance

By Cause

  • Fasting hypoglycaemia: Insulinoma, adrenal insufficiency, liver failure
  • Reactive hypoglycaemia: Post-prandial, dumping syndrome
  • Drug-induced: Insulin, sulphonylureas, alcohol

Investigations

Immediate

  • Capillary blood glucose: Confirm hypoglycaemia
  • Venous glucose: If CBG uncertain
  • Lab glucose during episode: Gold standard (Whipple's triad)

If Cause Unclear (Non-Diabetic)

  • C-peptide + insulin: During hypoglycaemic episode
  • Beta-hydroxybutyrate: Suppressed in insulinoma
  • Sulphonylurea screen: Rule out factitious/accidental
  • Cortisol: Adrenal insufficiency
  • IGF-1, IGF-2: Non-islet cell tumours
  • Liver and renal function: Impaired metabolism

Whipple's Triad (Diagnostic)

  1. Symptoms of hypoglycaemia
  2. Documented low blood glucose
  3. Symptom resolution with glucose administration

Management

Conscious Patient (Self-Treating)

Oral fast-acting glucose:

  • 15-20g fast-acting carbohydrate
  • Examples: Lucozade 100ml, glucose tablets ×4, orange juice 200ml
  • Recheck glucose after 15 minutes
  • Repeat if still below 4.0 mmol/L
  • Follow with long-acting carbohydrate (biscuits, bread)

Unconscious/Unable to Swallow

IM Glucagon:

  • Dose: 1mg IM (or SC)
  • Onset: 10-15 minutes
  • Less effective if: Alcohol, liver disease, prolonged fast

IV Dextrose:

  • 10% glucose: 150-200ml over 15 minutes (preferred)
  • 20% glucose: 75-100ml via large vein
  • 50% glucose: Avoid if possible (vesicant, phlebitis)

Special Situations

Sulphonylurea-Induced:

  • Admit for 24-48 hours observation
  • IV dextrose infusion may be needed
  • Consider octreotide 50mcg SC if recurrent

Post-Gastric Surgery:

  • Dumping syndrome
  • Small frequent meals, low GI carbohydrates

Prevention

  • Structured education (DAFNE for Type 1)
  • CGM with alarms if hypoglycaemia unawareness
  • Review insulin/sulphonylurea doses
  • Glucagon kit prescription

Complications

Acute

  • Seizures
  • Aspiration
  • Cardiac arrhythmias (QT prolongation)
  • Injuries from falls
  • Road traffic accidents

Long-term

ComplicationImpact
Hypoglycaemia unawareness6× risk of severe hypoglycaemia
Cognitive impairmentRisk with recurrent severe episodes
Cardiovascular eventsArrhythmias, ischaemia during hypos
Quality of lifeFear of hypoglycaemia affects control

Prognosis

Outcomes

  • Most episodes: Resolve without sequelae
  • Severe prolonged hypoglycaemia: Can cause permanent brain damage
  • Dead-in-bed syndrome: Rare, young Type 1 patients

Risk of Recurrence

  • Previous severe hypo: Strongest predictor
  • Impaired awareness: 6× increased risk
  • Long duration of diabetes: Progressive risk

Key Evidence

Key Studies

DCCT/EDIC PMID: 8366922

  • Intensive insulin therapy reduced microvascular complications
  • Increased hypoglycaemia (62 vs 19 per 100 patient-years)

ACCORD PMID: 18539917

  • Intensive control in Type 2 increased mortality
  • Hypoglycaemia implicated as possible mechanism

Guidelines

  • JBDS Hypoglycaemia Guidelines (2022)
  • ADA Standards of Care 2024
  • NICE NG28 Type 2 Diabetes

Patient & Family Information

What is Hypoglycaemia?

Hypoglycaemia (a "hypo") happens when your blood sugar drops too low. It can make you feel shaky, sweaty, and confused. If not treated quickly, it can cause you to pass out.

Warning Signs

  • Feeling shaky or trembling
  • Sweating
  • Feeling hungry
  • Confusion or difficulty concentrating
  • Feeling anxious or irritable

What to Do

If you can swallow:

  • Take 15-20g of fast-acting sugar (juice, glucose tablets, sweets)
  • Wait 15 minutes
  • Recheck and repeat if still feeling unwell
  • Eat something substantial afterwards

If someone is unconscious:

  • Put them in the recovery position
  • Give glucagon injection if trained
  • Call 999

Prevention Tips

  • Regular meal times
  • Always carry fast-acting glucose
  • Check blood sugar before driving
  • Tell people around you about hypos

Resources

  • Diabetes UK Hypos
  • JDRF

Last updated: 2024-12-21

At a Glance

EvidenceHigh
Last Updated2024-12-21
Emergency Protocol

Red Flags

  • GCS below 8 or seizure
  • Unable to self-treat
  • Recurrent hypoglycaemia
  • Hypoglycaemia unawareness
  • Prolonged hypoglycaemia over 30 minutes
  • Post-sulphonylurea hypoglycaemia (can recur)

Clinical Pearls

  • "4 is the floor" — treat any glucose below 4.0 mmol/L even if asymptomatic
  • Sulphonylurea-induced hypoglycaemia can last 24-72 hours — ADMIT
  • Rebound hyperglycaemia after treatment is common — avoid overtreating

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines